US Stock MarketDetailed Quotes

DHR Danaher

Watchlist
  • 249.720
  • +0.950+0.38%
Close Mar 28 16:00 ET
  • 249.720
  • 0.0000.00%
Post 17:35 ET
184.93BMarket Cap39.14P/E (TTM)

About Danaher Company

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Company Profile

SymbolDHR
Company NameDanaher
Listing Date12/10/1969
Founded1984
CEOMr. Rainer M. Blair
MarketNYSE
Employees63000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue North West,Suite 800 West
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037-1701
Phone1-202-828-0850

Company Executives

  • Name
  • Position
  • Salary
  • Rainer M. Blair
  • Director, President and Chief Executive Officer
  • 20.90M
  • Matthew R. McGrew
  • Executive Vice President and Chief Financial Officer
  • 7.50M
  • Dr. Jose-Carlos Gutierrez-Ramos, PhD
  • Senior Vice President and Chief Scientific Officer
  • 7.20M
  • Christopher M. Bouda
  • Vice President and Chief Accounting Officer
  • --
  • Joakim Weidemanis
  • Executive Vice President
  • 8.47M
  • Daniel A. Raskas
  • Senior Vice President, Corporate Development
  • --
  • William H. King
  • Senior Vice President, Strategic Development
  • --
  • Brian W. Ellis
  • Senior Vice President and General Counsel
  • 3.56M
  • Georgeann F. Couchara
  • Senior Vice President, Human Resources
  • 5.25M
  • Christopher Paul Riley
  • Executive Vice President
  • --
  • Steven M. Rales
  • Chairman of the Board
  • --
  • Mitchell P. Rales
  • Director
  • --
  • Alan G. Spoon, J.D.
  • Independent Director
  • 338.13K
  • Linda Hefner Filler
  • Lead Independent Director
  • 382.13K
  • John T. Schwieters
  • Independent Director
  • 351.13K
  • Walter G. Lohr, Jr
  • Independent Director
  • 328.13K
  • Dr. Elias A. Zerhouni, M.D.
  • Independent Director
  • 338.13K
  • Teri L. List-Stoll
  • Independent Director
  • 318.13K
  • Feroz Dewan
  • Independent Director
  • 318.13K
  • Professor Raymond C. Stevens, PhD
  • Independent Director
  • 318.13K
  • Dr. Jessica L. Mega, M.D.,M.P.H.
  • Independent Director
  • 318.13K
  • Dr. Pardis C. Sabeti, M.D.
  • Independent Director
  • 318.13K
  • A. Shane Sanders
  • Independent Director
  • 320.13K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg